Advertisement
Screener

LIPOCINE INC. (LPCN) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

LIPOCINE INC. Operating Cash Flow

LIPOCINE INC. (LPCN) reported Operating Cash Flow of -$5.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04

  • LIPOCINE INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$3.03M.
  • LIPOCINE INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.26M.
  • LIPOCINE INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.92M, a 271.54% decline year-over-year.
  • LIPOCINE INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$2.99M.
  • LIPOCINE INC. net cash provided by (used in) operating activities for fiscal 2025 was -$9.76M.
  • LIPOCINE INC. net cash provided by (used in) operating activities for fiscal 2024 was -$1.22M.
  • LIPOCINE INC. net cash provided by (used in) operating activities for fiscal 2023 was -$11.87M.
  • LIPOCINE INC. net cash provided by (used in) operating activities for fiscal 2022 was -$11.97M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filedNet Cash Provided by (Used in) Operating Activities 15 monthNet Cash Provided by (Used in) Operating Activities 18 monthNet Cash Provided by (Used in) Operating Activities 21 month
2026-06-30-$3.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$5.29M
10-Q · filed 2026-08-04
-$8.21M
derived: sum of 3 quarters · filed 2026-08-04
-$11.19M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31-$2.26M
10-Q · filed 2026-05-07
-$5.18M
derived: sum of 2 quarters · filed 2026-05-07
-$8.16M
derived: sum of 3 quarters · filed 2026-05-07
-$10.05M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$2.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
-$5.91M
derived: sum of 2 quarters · filed 2026-03-10
-$7.79M
derived: sum of 3 quarters · filed 2026-08-04
-$9.76M
10-K · filed 2026-03-10
2025-09-30-$2.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$4.87M
derived: sum of 2 quarters · filed 2026-08-04
-$6.84M
10-Q · filed 2025-11-06
-$5.14M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$1.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$3.86M
10-Q · filed 2026-08-04
-$2.15M
derived: sum of 3 quarters · filed 2026-08-04
-$4.99M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31-$1.97M
10-Q · filed 2026-05-07
-$267.33K
derived: sum of 2 quarters · filed 2026-05-07
-$3.10M
derived: sum of 3 quarters · filed 2026-05-07
-$5.60M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
-$1.13M
derived: sum of 2 quarters · filed 2026-03-10
-$3.63M
derived: sum of 3 quarters · filed 2026-03-10
-$1.22M
10-K · filed 2026-03-10
2024-09-30-$2.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$5.33M
derived: sum of 2 quarters · filed 2025-11-06
-$2.92M
10-Q · filed 2025-11-06
-$4.95M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$2.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
-$90.26K
10-Q · filed 2025-08-05
-$2.11M
derived: sum of 3 quarters · filed 2025-08-05
-$4.72M
derived: sum of 4 quarters · filed 2025-08-05
2024-03-31$2.41M
10-Q · filed 2025-05-08
$385.21K
derived: sum of 2 quarters · filed 2025-05-08
-$2.22M
derived: sum of 3 quarters · filed 2025-05-08
-$5.53M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31-$2.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13
-$4.63M
derived: sum of 2 quarters · filed 2025-03-13
-$7.94M
derived: sum of 3 quarters · filed 2025-03-13
-$11.87M
10-K · filed 2025-03-13
2023-09-30-$2.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$5.92M
derived: sum of 2 quarters · filed 2024-11-07
-$9.84M
10-Q · filed 2024-11-07
-$11.68M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$3.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$7.24M
10-Q · filed 2024-08-08
-$9.08M
derived: sum of 3 quarters · filed 2024-08-08
-$12.27M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$3.93M
10-Q · filed 2024-05-09
-$5.77M
derived: sum of 2 quarters · filed 2024-05-09
-$8.97M
derived: sum of 3 quarters · filed 2024-05-09
-$12.01M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$1.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07
-$5.04M
derived: sum of 2 quarters · filed 2024-03-07
-$8.08M
derived: sum of 3 quarters · filed 2024-03-07
-$11.97M
10-K · filed 2024-03-07
2022-09-30-$3.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$6.24M
derived: sum of 2 quarters · filed 2023-11-08
-$10.13M
10-Q · filed 2023-11-08
-$1.14M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30-$3.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
-$6.93M
10-Q · filed 2023-08-10
$2.06M
derived: sum of 3 quarters · filed 2023-08-10
-$4.92M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$3.89M
10-Q · filed 2023-05-11
$5.11M
derived: sum of 2 quarters · filed 2023-05-11
-$1.87M
derived: sum of 3 quarters · filed 2023-05-11
-$4.23M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$8.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10
$2.01M
derived: sum of 2 quarters · filed 2023-03-10
-$349.53K
derived: sum of 3 quarters · filed 2023-03-10
-$4.41M
10-K · filed 2023-03-10
2021-09-30-$6.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$9.34M
derived: sum of 2 quarters · filed 2022-11-09
-$13.41M
10-Q · filed 2022-11-09
-$17.09M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-$2.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$6.43M
10-Q · filed 2022-08-08
-$10.11M
derived: sum of 3 quarters · filed 2022-08-08
-$14.27M
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31-$4.06M
10-Q · filed 2022-05-09
-$7.75M
derived: sum of 2 quarters · filed 2022-05-09
-$11.91M
derived: sum of 3 quarters · filed 2022-05-09
-$15.99M
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31-$3.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09
-$7.85M
derived: sum of 2 quarters · filed 2022-03-09
-$11.93M
derived: sum of 3 quarters · filed 2022-03-09
-$15.30M
10-K · filed 2022-03-09
2020-09-30-$4.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
-$8.24M
derived: sum of 2 quarters · filed 2021-11-10
-$11.62M
10-Q · filed 2021-11-10
-$14.93M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$4.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$7.46M
10-Q · filed 2021-08-05
-$10.76M
derived: sum of 3 quarters · filed 2021-08-05
-$13.56M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31-$3.38M
10-Q · filed 2021-05-06
-$6.68M
derived: sum of 2 quarters · filed 2021-05-06
-$9.48M
derived: sum of 3 quarters · filed 2021-05-06
-$12.04M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31-$3.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
-$6.11M
derived: sum of 2 quarters · filed 2021-03-11
-$8.66M
derived: sum of 3 quarters · filed 2021-03-11
-$11.67M
10-K · filed 2021-03-11
2019-09-30-$2.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
-$5.36M
derived: sum of 2 quarters · filed 2020-11-10
-$8.36M
10-Q · filed 2020-11-10
-$10.59M
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30-$2.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$5.56M
10-Q · filed 2020-08-06
-$7.79M
derived: sum of 3 quarters · filed 2020-08-06
-$11.15M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$3.00M
10-Q · filed 2020-05-07
-$5.24M
derived: sum of 2 quarters · filed 2020-05-07
-$8.60M
derived: sum of 3 quarters · filed 2020-05-07
-$11.34M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31-$2.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
-$5.59M
derived: sum of 2 quarters · filed 2020-03-13
-$8.33M
derived: sum of 3 quarters · filed 2020-03-13
-$12.08M
10-K · filed 2020-03-13
2018-09-30-$3.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$6.10M
derived: sum of 2 quarters · filed 2019-11-12
-$9.85M
10-Q · filed 2019-11-12
-$14.14M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$2.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
-$6.49M
10-Q · filed 2019-08-07
-$10.78M
derived: sum of 3 quarters · filed 2019-08-07
-$15.35M
derived: sum of 4 quarters · filed 2019-08-07
2018-03-31-$3.75M
10-Q · filed 2019-05-08
-$8.04M
derived: sum of 2 quarters · filed 2019-05-08
-$12.61M
derived: sum of 3 quarters · filed 2019-05-08
-$17.31M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31-$4.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
-$8.86M
derived: sum of 2 quarters · filed 2019-03-06
-$13.56M
derived: sum of 3 quarters · filed 2019-03-06
-$16.70M
10-K · filed 2019-03-06
2017-09-30-$4.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
-$9.27M
derived: sum of 2 quarters · filed 2018-11-07
-$12.41M
10-Q · filed 2018-11-07
-$14.95M
derived: sum of 4 quarters · filed 2019-03-06
2017-06-30-$4.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
-$7.84M
10-Q · filed 2018-08-07
-$10.39M
derived: sum of 3 quarters · filed 2019-03-06
2017-03-31-$3.14M
10-Q · filed 2018-05-07
-$5.69M
derived: sum of 2 quarters · filed 2019-03-06
2016-12-31-$2.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
-$18.28M
10-K · filed 2019-03-06
2016-09-30-$15.73M
10-Q · filed 2017-11-08
2015-12-31-$15.36M
10-K · filed 2018-03-12
2013-12-31-$4.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
-$8.59M
derived: sum of 2 quarters · filed 2014-03-31
-$8.59M
derived: sum of 3 quarters · filed 2014-03-31
-$8.59M
10-K · filed 2014-03-31
2013-09-30-$4.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13
-$4.48M
derived: sum of 2 quarters · filed 2013-11-13
-$4.48M
10-Q · filed 2013-11-13
-$5.51M
derived: sum of 4 quarters · filed 2014-03-31
2013-06-30-$448.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-09
-$567.00
10-Q · filed 2013-07-09
-$1.04M
derived: sum of 3 quarters · filed 2014-03-31
-$3.12M
derived: sum of 4 quarters · filed 2014-03-31
-$70.73K
10-Q · filed 2013-07-09
2013-03-31-$119.00
10-Q · filed 2013-04-24
-$1.04M
derived: sum of 2 quarters · filed 2014-03-31
-$3.12M
derived: sum of 3 quarters · filed 2014-03-31
-$3.17M
derived: sum of 4 quarters · filed 2014-03-31
-$70.28K
10-Q · filed 2013-04-24
2012-12-31-$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
-$3.12M
derived: sum of 2 quarters · filed 2014-03-31
-$3.17M
derived: sum of 3 quarters · filed 2014-03-31
-$3.18M
10-K · filed 2014-03-31
-$62.87K
10-K · filed 2013-02-26
-$70.16K
10-K · filed 2013-02-26
2012-09-30-$2.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13
-$2.13M
derived: sum of 2 quarters · filed 2013-11-13
-$2.14M
10-Q · filed 2013-11-13
-$62.82K
10-Q · filed 2012-10-26
-$70.12K
10-Q · filed 2012-10-26
2012-06-30-$54.96K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-09
-$60.01K
10-Q · filed 2013-07-09
-$67.30K
10-Q · filed 2012-07-18
2012-03-31-$5.05K
10-Q · filed 2013-04-24
-$12.35K
10-Q · filed 2012-05-14
2011-12-31-$7.29K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
-$7.29K
10-K · filed 2013-02-26
2011-09-30$0.00
10-Q · filed 2012-10-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Rocket One Inc. (RKTO)United States$0.019B
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03